Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report
Purpose: To report a case of endogenous panophthalmitis in a patient with COVID-19 during treatment in an Intensive Care Unit. Observation: A 64‐year‐old woman with COVID-19 and Salmonella septicemia presented with decreased visual acuity, ocular pain, and proptosis in her right eye after treatment...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | American Journal of Ophthalmology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993622004534 |
_version_ | 1811311134870863872 |
---|---|
author | Sinsucha Boontantrapiwat Duangnate Rojanaporn Weerawan Chokthaweesak Naris Kitnarong |
author_facet | Sinsucha Boontantrapiwat Duangnate Rojanaporn Weerawan Chokthaweesak Naris Kitnarong |
author_sort | Sinsucha Boontantrapiwat |
collection | DOAJ |
description | Purpose: To report a case of endogenous panophthalmitis in a patient with COVID-19 during treatment in an Intensive Care Unit. Observation: A 64‐year‐old woman with COVID-19 and Salmonella septicemia presented with decreased visual acuity, ocular pain, and proptosis in her right eye after treatment with favipiravir, intravenous dexamethasone, and ceftriaxone. An ocular examination of her right eye revealed periorbital tenderness, exophthalmos, and corneal haze. The ultrasonography showed a subretinal abscess. Her right eye lost light perception vision and underwent enucleation. Microbiologic evaluation of the enucleated right eye was negative for organisms. Conclusions and importance: Patents with COVID-19 may develop severe ocular involvement after COVID-19 due to a generalized reduction in immunity. Comorbidities and intensive care unit treatments can predispose COVID-19 patients to endogenous panophthalmitis. |
first_indexed | 2024-04-13T10:12:24Z |
format | Article |
id | doaj.art-d8c658c063644afabdf29135eae4858c |
institution | Directory Open Access Journal |
issn | 2451-9936 |
language | English |
last_indexed | 2024-04-13T10:12:24Z |
publishDate | 2022-12-01 |
publisher | Elsevier |
record_format | Article |
series | American Journal of Ophthalmology Case Reports |
spelling | doaj.art-d8c658c063644afabdf29135eae4858c2022-12-22T02:50:52ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362022-12-0128101707Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case reportSinsucha Boontantrapiwat0Duangnate Rojanaporn1Weerawan Chokthaweesak2Naris Kitnarong3Krathumbaen Hospital, ThailandDepartment of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, ThailandDepartment of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, ThailandDepartment of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand; Corresponding author. Department of Ophthalmology Faculty of Medicine Siriraj Hospital, Mahidol University 2 Prannok Road, Bangkoknoi, Bangkok, 10700, Thailand.Purpose: To report a case of endogenous panophthalmitis in a patient with COVID-19 during treatment in an Intensive Care Unit. Observation: A 64‐year‐old woman with COVID-19 and Salmonella septicemia presented with decreased visual acuity, ocular pain, and proptosis in her right eye after treatment with favipiravir, intravenous dexamethasone, and ceftriaxone. An ocular examination of her right eye revealed periorbital tenderness, exophthalmos, and corneal haze. The ultrasonography showed a subretinal abscess. Her right eye lost light perception vision and underwent enucleation. Microbiologic evaluation of the enucleated right eye was negative for organisms. Conclusions and importance: Patents with COVID-19 may develop severe ocular involvement after COVID-19 due to a generalized reduction in immunity. Comorbidities and intensive care unit treatments can predispose COVID-19 patients to endogenous panophthalmitis.http://www.sciencedirect.com/science/article/pii/S2451993622004534COVID-19Endogenous panophthalmitisEnucleationEndophthalmitisOcular manifestationSalmonella septicemia |
spellingShingle | Sinsucha Boontantrapiwat Duangnate Rojanaporn Weerawan Chokthaweesak Naris Kitnarong Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report American Journal of Ophthalmology Case Reports COVID-19 Endogenous panophthalmitis Enucleation Endophthalmitis Ocular manifestation Salmonella septicemia |
title | Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report |
title_full | Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report |
title_fullStr | Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report |
title_full_unstemmed | Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report |
title_short | Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report |
title_sort | endogenous panophthalmitis in a patient with covid 19 during hospitalization in an intensive care unit a case report |
topic | COVID-19 Endogenous panophthalmitis Enucleation Endophthalmitis Ocular manifestation Salmonella septicemia |
url | http://www.sciencedirect.com/science/article/pii/S2451993622004534 |
work_keys_str_mv | AT sinsuchaboontantrapiwat endogenouspanophthalmitisinapatientwithcovid19duringhospitalizationinanintensivecareunitacasereport AT duangnaterojanaporn endogenouspanophthalmitisinapatientwithcovid19duringhospitalizationinanintensivecareunitacasereport AT weerawanchokthaweesak endogenouspanophthalmitisinapatientwithcovid19duringhospitalizationinanintensivecareunitacasereport AT nariskitnarong endogenouspanophthalmitisinapatientwithcovid19duringhospitalizationinanintensivecareunitacasereport |